Fundraising FoxadMare BioInnovations
Venture studioVancouver · Seed
Find your way into adMare BioInnovations
Sign up to find every way you can get introduced to adMare BioInnovations
- Your email: who you already know at adMare BioInnovations, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the adMare BioInnovations team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
adMare BioInnovations aims to position Canada as a global leader in life sciences by focusing on three pillars: building companies, building ecosystems, and building talent. Working alongside partners in government, academia, industry, and the investment community, it applies scientific and commercial expertise, specialized R&D infrastructure, and seed capital to grow strong life sciences ventures. Returns generated are reinvested back into the Canadian life sciences industry to ensure its long-term sustainability and to develop industry-ready talent.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 8 of 10 portfolio companiesBiotech ×5Medical Devices ×3Digital Health ×2Healthtech ×2Impact & Social Good ×2SaaS ×2AI & Machine Learning ×1Cloud Computing ×1
HQs:Canada×4United States×1
Investments · 10 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12020 · 13 dated
Find Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair.
BiotechLongevityMedical DevicesMontreal, CA
Co-investorsCTI Life Sciences Fund L.P.
Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.
BiotechHealthtechMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin
Co-investorsAmzak HealthAlexandriaCTI Life Sciences Fund L.P.Lumira Ventures
Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
BiotechDigital HealthMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in
BoardSaumya Das(Chief Scientific Advisor)
Co-investorsLumira VenturesAmzak HealthCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
ADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally.
Cloud ComputingEnterprise SoftwareHR TechSaaSRoseland, US
Co-investorsADP VenturesBraemont CapitalValor Equity Partners
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.
BiotechDigital Health
Co-investors3B Future Health FundCTI Life Sciences Fund L.P.Omnes CapitalPanacea VentureSeventure Partners
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesAmgen Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Abdera
Exits · 1
1 acquisitionsInversagoacq. by Novo Nordisk
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has adMare BioInnovations made?
- adMare BioInnovations has 10 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does adMare BioInnovations invest at?
- adMare BioInnovations invests at the Seed stage.
- What sectors does adMare BioInnovations focus on?
- adMare BioInnovations focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is adMare BioInnovations located?
- adMare BioInnovations is headquartered in Vancouver, CA.
- Who does adMare BioInnovations co-invest with?
- adMare BioInnovations most often shares deals with ADP Ventures, Braemont Capital, Valor Equity Partners, among 3 tracked co-investors.
Media · Podcasts & interviews
from their channelADMARE'S CROSS-CANADA VIRTUAL ROADTRIP - British Columbia Stop
adMare BioInnovations
CIHR webinar - Team Grant : Preparation to Trial: Inflammation for Chronic Conditions
adMare BioInnovations
CARI Webinar
adMare BioInnovations
adMare Academy Community - Getting Started Basic Navigation
adMare BioInnovations
What is the Executive Institute?
adMare BioInnovations
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Connecticut Innovations is the state of Connecticut's venture capital arm, providing financing and ongoing strategic support to innovative, growing companies based in Connecticut.
Elm Street Ventures is a seed and early-stage venture fund in New Haven, Connecticut that primarily backs companies with a Yale connection, especially technology developed at and licensed from Yale.
Industrifonden is a Sweden-based venture capital fund investing in scalable, science- and technology-driven ventures across the Nordics.